The basal ganglia: A central hub for the psychomotor effects of electroconvulsive therapy

2020 ◽  
Vol 265 ◽  
pp. 239-246 ◽  
Author(s):  
Jan-Baptist Belge ◽  
Linda Van Diermen ◽  
Didier Schrijvers ◽  
Bernard Sabbe ◽  
Eric Constant ◽  
...  
1966 ◽  
Vol 112 (491) ◽  
pp. 983-987 ◽  
Author(s):  
I. G. Pryce ◽  
H. Edwards

An association between certain persistent oral dyskinesias and medication with phenothiazines has been observed in middle-aged and elderly women for several years. In most of the published reports it is held that the phenothiazines are an important cause of the abnormal movements, since phenothiazines are known to exert a selective action on the basal ganglia. Other possible causes, however, are almost invariably present. These are brain damage from disease, leucotomy or electroconvulsive therapy (Hunter, Earl and Janz, 1964; Hunter, Earl and Thornicroft, 1964; Uhrbrand and Faurbye, 1960), and buccal factors such as ill-fitting dentures or the edentulous state (Joyston-Bechal, 1965; Evans, 1965). Similar dyskinesias are also said to occur with brain damage when phenothiazines have not been given (Rosin and Exton-Smith, 1965).


2017 ◽  
Vol 36 (3) ◽  
pp. 930-935
Author(s):  
OOE Ajibola ◽  
L Ogunwolu

Huntington’s disease (HD) which usually affects the patients at middle age results from malfunctioning of the basal ganglia. It is characterized by cognitive impairment, involuntary movements, neuropsychiatric and psychological disturbances. Early motor signs of Huntington’s disease typically include the gradual onset of clumsiness, balance difficulties, and brief, random, fidgeting movements. A popular approach to solving symptoms arising from HD has been through the administration of drugs. But drugs debase human activities, thus the application of electroconvulsive therapy. This work proposes a genetic algorithmic (GA) simulation of chorea in HD patient as a pedestal for the design of a therapeutic device aimed at managing the phenomenon. Earlier efforts have led us to the formulation of such models in recent past. We also compared the GA model with our foremost effort: the electromechanical model, and we observe that the GA model adequately capture the physiological presentation of gait phenomenon in Huntington’s disease. http://dx.doi.org/10.4314/njt.v36i3.37


Author(s):  
Frank Häßler ◽  
Olaf Reis ◽  
Steffen Weirich ◽  
Jacqueline Höppner ◽  
Birgit Pohl ◽  
...  

This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine. Under a combined treatment with amantadine, electroconvulsive therapy (ECT), and (currently) ziprasidone alone she improved markedly. Severity and course of catatonia including treatment response were evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). This case report emphasizes the benefit of ECT in the treatment of catatonic symptoms in an adolescent patient with schizophrenic illness.


1994 ◽  
Vol 39 (1) ◽  
pp. 39-40
Author(s):  
P. V. Nickell

2008 ◽  
Author(s):  
L. Rami ◽  
J. Goti ◽  
J. Ferrer ◽  
T. Marcos ◽  
M. Salamero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document